1. Home
  2. MWH vs EWTX Comparison

MWH vs EWTX Comparison

Compare MWH & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOLV Energy Inc. Class A Common Stock

MWH

SOLV Energy Inc. Class A Common Stock

SELL

Current Price

$23.64

Market Cap

5.3B

Sector

Industrials

ML Signal

SELL

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

SELL

Current Price

$37.21

Market Cap

4.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MWH
EWTX
Founded
2008
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.3B
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
MWH
EWTX
Price
$23.64
$37.21
Analyst Decision
Strong Buy
Buy
Analyst Count
11
13
Target Price
$43.00
★ $52.62
AVG Volume (30 Days)
1.1M
★ 1.4M
Earning Date
08-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.11
N/A
Revenue
N/A
N/A
Revenue This Year
$58.24
N/A
Revenue Next Year
$15.21
N/A
P/E Ratio
$217.82
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.12
$14.68
52 Week High
$48.40
$48.51

Technical Indicators

Market Signals
Indicator
MWH
EWTX
Relative Strength Index (RSI) 40.00 37.89
Support Level $23.71 $30.66
Resistance Level $27.27 $41.22
Average True Range (ATR) 1.13 1.64
MACD -0.05 -0.25
Stochastic Oscillator 23.06 28.73

Price Performance

Historical Comparison
MWH
EWTX

About MWH SOLV Energy Inc. Class A Common Stock

SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: